Antioxidants: Friend or foe?

被引：90
|
作者：
Sarangarajan, R. [1 ]
Meera, S. [2 ]
Rukkumani, R. [3 ]
Sankar, P. [3 ]
Anuradha, G. [4 ]
机构：
[1] Madha Dent Coll, Dept Oral Pathol, Madras, Tamil Nadu, India
[2] Sree Sai Dent Care, Madras, Tamil Nadu, India
[3] Pondicherry Univ, Sch Life Sci, Dept Biochem & Mol Biol, Pondicherry, India
[4] Sai Raghav Dent Clin, Madras, Tamil Nadu, India
来源：
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE | 2017年 / 10卷 / 12期
关键词：
Antioxidants; Oxidative stress; Reactive oxygen species; Therapeutic agent; CARDIOVASCULAR-DISEASE; MOLECULAR-MECHANISMS; PERINATAL ASPHYXIA; OXIDATIVE STRESS; N-ACETYLCYSTEINE; ROS PRODUCTION; BETA-CAROTENE; OXYGEN; VITAMINS; RADICALS;
D O I：
10.1016/j.apjtm.2017.10.017
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Reactive oxygen species are the intermediates that are formed during the normal metabolic process which are effectively neutralized by the antioxidant system of the body. Any imbalance in this neutralization process causes oxidative stress which has been implicated as one of the cause in diseases such as Alzheimer's disease, cardiovascular disorders, cancer etc. Research has enabled the use of antioxidants as therapeutic agents in the treatment of various diseases. Literature also puts forth the negative effects of using antioxidants in the treatment of diseases. This review is a compilation of both the beneficial and detrimental effects of use of antioxidants in the treatment of diseases such as cancer, cardiovascular diseases, diabetes and oral diseases.
引用
收藏
页码：1111 / 1116
页数：6
相关论文
共 50 条
  • [21] Mitochondrial stress: Balancing friend and foe
    Runkel, Eva Diana
    Baumeister, Ralf
    Schulze, Ekkehard
    EXPERIMENTAL GERONTOLOGY, 2014, 56 : 194 - 201
  • [22] Oxygen in the critically ill: friend or foe?
    Damiani, Elisa
    Donati, Abele
    Girardis, Massimo
    CURRENT OPINION IN ANESTHESIOLOGY, 2018, 31 (02) : 129 - 135
  • [23] S-glutathionylation, friend or foe in cardiovascular health and disease
    Rashdan, N. A.
    Shrestha, B.
    Pattillo, C. B.
    REDOX BIOLOGY, 2020, 37
  • [24] The Role of NRF2 in Bone Metabolism - Friend or Foe?
    Han, Jie
    Yang, Kuan
    An, Jinyang
    Jiang, Na
    Fu, Songbo
    Tang, Xulei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [25] Friend or foe? The dual role of triptolide in the liver, kidney, and heart
    Jiang, Shiyuan
    Wan, Feng
    Lian, Hui
    Lu, Zhihao
    Li, Xueming
    Cao, Dan
    Jiang, Yangyu
    Li, Jian
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [26] Calcium and Reactive Oxygen Species in Acute Pancreatitis: Friend or Foe?
    Booth, David M.
    Mukherjee, Rajarshi
    Sutton, Robert
    Criddle, David N.
    ANTIOXIDANTS & REDOX SIGNALING, 2011, 15 (10) : 2683 - 2698
  • [27] Aspirin: Friend or Foe?
    Bronkhorst, Elmien
    De Klerk, Hanneke
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (03) : 27 - 30
  • [28] The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
    Glorieux, Christophe
    Enriquez, Cinthya
    Gonzalez, Constanza
    Aguirre-Martinez, Gabriela
    Calderon, Pedro Buc
    ANTIOXIDANTS, 2024, 13 (01)
  • [29] The 'polypill', friend or foe?
    Rafter, Natasha
    Woodward, Alistair
    AUSTRALIAN PRESCRIBER, 2005, 28 (04) : 82 - 83
  • [30] The Nox Family of NADPH Oxidases: Friend or Foe of the Vascular System?
    Takac, Ina
    Schroeder, Katrin
    Brandes, Ralf P.
    CURRENT HYPERTENSION REPORTS, 2012, 14 (01) : 70 - 78
12345